AL
CTMX icon

AJO LP’s CytomX Therapeutics CTMX Stock Holding History

AJO LP’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-66,641
Closed -$443K – 362
2020
Q3 		$443K Buy
+66,641
New +$494K ﹤0.01% 545
2018
Q3 		– Sell
-21,179
Closed -$484K – 662
2018
Q2 		$484K Sell
21,179
-852
-4% -$21.8K ﹤0.01% 582
2018
Q1 		$627K Sell
22,031
-20,365
-48% -$581K ﹤0.01% 542
2017
Q4 		$895K Buy
+42,396
New +$879K ﹤0.01% 504

Other funds holding CTMX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJO LP's CTMX Position: Q4 2020 in Review

AJO LP sold out of CytomX Therapeutics (CTMX) in Q4 2020, closing a stake of 66,641 shares — an estimated $443K sold.

AJO LP first reported a position in CTMX in Q4 2017 and held it in 4 quarters. The position peaked at $895K in Q4 2017. 126 funds tracked by Wall St. Rank hold CTMX as of Q4 2020.

  • AJO LP reported no remaining CytomX Therapeutics position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 66,641 CytomX Therapeutics shares in Q4 2020, an estimated $443K.
  • AJO LP first reported a position in CytomX Therapeutics in Q4 2017 and held it in 4 quarters.
  • AJO LP's CytomX Therapeutics position peaked at $895K in Q4 2017.
  • 126 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.